Search Results
Search for other papers by Shilpa Lingaiah in
Google Scholar
PubMed
Search for other papers by Laure Morin-Papunen in
Google Scholar
PubMed
Search for other papers by Terhi Piltonen in
Google Scholar
PubMed
Search for other papers by Inger Sundström-Poromaa in
Google Scholar
PubMed
Search for other papers by Elisabet Stener-Victorin in
Google Scholar
PubMed
Department of Obstetrics and Gynaecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Search for other papers by Juha S Tapanainen in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, with an estimated prevalence of 6–15%, depending on the criteria used for diagnosis ( 1 ). It is a heterogeneous disorder with
Search for other papers by Małgorzata Kałużna in
Google Scholar
PubMed
Search for other papers by Agnieszka Nomejko in
Google Scholar
PubMed
Search for other papers by Aleksandra Słowińska in
Google Scholar
PubMed
Search for other papers by Katarzyna Wachowiak-Ochmańska in
Google Scholar
PubMed
Search for other papers by Katarzyna Pikosz in
Google Scholar
PubMed
Search for other papers by Katarzyna Ziemnicka in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is a common condition, affecting up to 20% of reproductive-aged women ( 1 , 2 ). PCOS is associated with significant hormonal, reproductive , metabolic, and psychological concerns. PCOS is
Search for other papers by Małgorzata Kałużna in
Google Scholar
PubMed
Search for other papers by Pola Kompf in
Google Scholar
PubMed
Search for other papers by Katarzyna Wachowiak-Ochmańska in
Google Scholar
PubMed
Search for other papers by Jerzy Moczko in
Google Scholar
PubMed
Search for other papers by Aleksandra Królczyk in
Google Scholar
PubMed
Search for other papers by Adam Janicki in
Google Scholar
PubMed
Search for other papers by Karol Szapel in
Google Scholar
PubMed
Search for other papers by Marian Grzymisławski in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
Search for other papers by Katarzyna Ziemnicka in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is a complex endocrinopathy characterized by chronic, low-grade inflammation with features such as clinical and/or biochemical hyperandrogenism, oligo- or anovulation and a characteristic image of
Search for other papers by Teresa Vilariño-García in
Google Scholar
PubMed
Search for other papers by Antonio Pérez-Pérez in
Google Scholar
PubMed
Search for other papers by Esther Santamaría-López in
Google Scholar
PubMed
Search for other papers by Nicolás Prados in
Google Scholar
PubMed
Search for other papers by Manuel Fernández-Sánchez in
Google Scholar
PubMed
Search for other papers by Víctor Sánchez-Margalet in
Google Scholar
PubMed
different cellular system. Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects 5–10% of women at reproductive age ( 15 ). It has unknown origin and various clinical presentations during the life span. PCOS is characterized
Search for other papers by Katica Bajuk Studen in
Google Scholar
PubMed
Search for other papers by Marija Pfeifer in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is a common disorder in women of reproductive age, with a prevalence 5–16% under different diagnostic criteria and across several ethnic groups, with exact pathogenesis still unclear ( 1 , 2 , 3
Search for other papers by Yao Chen in
Google Scholar
PubMed
Search for other papers by Shu-ying Fang in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is a heterogeneous and complex disorder of reproductive aged women, which usually causes reproduction and metabolism failure ( 1 , 2 ). It often presents as hyperandrogenism, hyperinsulinemia
Search for other papers by Michelle Hadjiconstantinou in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK
Search for other papers by Hamidreza Mani in
Google Scholar
PubMed
Search for other papers by Naina Patel in
Google Scholar
PubMed
Search for other papers by Miles Levy in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK
Search for other papers by Melanie Davies in
Google Scholar
PubMed
Search for other papers by Kamlesh Khunti in
Google Scholar
PubMed
Search for other papers by Margaret Stone in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is the most common endocrine condition in women ( 1 ). It can have important consequences in relation to both physical and mental health ( 2 , 3 , 4 ) and increase the risk of type 2 diabetes (T2
Search for other papers by Angela Köninger in
Google Scholar
PubMed
Search for other papers by Philippos Edimiris in
Google Scholar
PubMed
Search for other papers by Laura Koch in
Google Scholar
PubMed
Search for other papers by Antje Enekwe in
Google Scholar
PubMed
Search for other papers by Claudia Lamina in
Google Scholar
PubMed
Search for other papers by Sabine Kasimir-Bauer in
Google Scholar
PubMed
Search for other papers by Rainer Kimmig in
Google Scholar
PubMed
Department of Gynecology and Obstetrics, Division of Genetic Epidemiology, Vitateq Biotechnology GmbH, University of Duisburg-Essen, D-45122 Essen, Germany
Search for other papers by Hans Dieplinger in
Google Scholar
PubMed
Introduction The polycystic ovary syndrome (PCOS) is one of the most frequent endocrine disorders, found in up to 8% of women of reproductive age (1) . According to the Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group, the diagnosis is
Search for other papers by Hong Tang in
Google Scholar
PubMed
Search for other papers by Xiaomei Jiang in
Google Scholar
PubMed
Search for other papers by Yu Hua in
Google Scholar
PubMed
Search for other papers by Heyue Li in
Google Scholar
PubMed
Search for other papers by Chunlan Zhu in
Google Scholar
PubMed
Search for other papers by Xiaobai Hao in
Google Scholar
PubMed
Search for other papers by Minhui Yi in
Google Scholar
PubMed
Search for other papers by Linxia Li in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is an androgen disorder and ovarian dysfunction disease in women of reproductive age. PCOS is responsible for more than 90% of adult and adolescent hyperandrogenism ( 1 , 2 ). The pathogenesis of
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Signe Kirkegaard in
Google Scholar
PubMed
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Nanna Maria Uldall Torp in
Google Scholar
PubMed
Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
prevail regarding the underlying mechanisms for the associations observed and as to whether thyroid function and/or autoimmunity is the key determinant ( 8 , 9 , 10 , 11 ). Endometriosis and polycystic ovary syndrome (PCOS) are common gynecological